Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).

Yui Y, Shinoda E, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases B (JMIC-B) Study Group.

J Hypertens. 2007 Oct;25(10):2019-26.

PMID:
17885543
2.

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group.

Hypertens Res. 2004 Mar;27(3):181-91.

3.

Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.

Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C.

Hypertens Res. 2004 Jul;27(7):449-56. Erratum in: Hypertens Res. 2004 Sep;27(9):695.

4.

[JMIC-B study and its sub-analyses: effect of nifedipine in Japanese hypertensive patients with coronary artery disease].

Yui Y.

Drugs. 2006;66 Spec No 1:25-7. Review. Japanese. Erratum in: Drugs. 2007;67(13):1849.

PMID:
18200776
5.

Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).

Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group.

Hypertension. 2005 Jun;45(6):1153-8. Epub 2005 Apr 25.

6.

Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.

Yui Y, Kodama K, Hirayama A, Nishio R, Iwanaga Y, Nonogi H, Haze K, Sumiyoshi T, Yui N, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases B (JMIC-B) Study Group.

J Hypertens. 2010 Jan;28(1):178-85. doi: 10.1097/HJH.0b013e3283324668.

PMID:
19927011
7.

Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.

Ikram H, Low CJ, Shirlaw TM, Foy SG, Crozier IG, Richards AM, Khurmi NS, Horsburgh RJ.

Br Heart J. 1994 Jan;71(1):30-3.

8.

Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.

Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A; Japanese Acute Myocardial Infarction Prospective study group.

Am Heart J. 2004 Aug;148(2):e8.

PMID:
15309011
9.
10.

Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).

Hirayama A, Kodama K, Yui Y, Nonogi H, Sumiyoshi T, Origasa H, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-Mochida Investigators.

Am J Cardiol. 2003 Oct 1;92(7):789-93.

PMID:
14516877
11.

Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris.

Blaustein AS, Heller GV, Kolman BS.

Am J Cardiol. 1983 Nov 1;52(8):950-4.

PMID:
6139007
12.

Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.

Boden WE, Korr KS, Bough EW.

JAMA. 1985 Feb 22;253(8):1131-5.

PMID:
2857206
13.

Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.

Hugenholtz PG, Michels HR, Serruys PW, Brower RW.

Am J Cardiol. 1981 Jan;47(1):163-73.

PMID:
6969985
14.

[Does quinapril improve coronary vasoconstriction in vasospastic angina?].

Anzai H, Saijo T, Nakajima R, Tezuka N, Takagi T, Tsunoda T, Kobayashi N, Nakamura S, Yamaguchi T.

J Cardiol. 2000 Dec;36(6):379-86. Japanese.

PMID:
11190581
15.

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M.

J Am Coll Cardiol. 2006 Feb 21;47(4):726-33. Epub 2006 Jan 26.

16.

Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.

Lubsen J, Vokó Z, Poole-Wilson PA, Kirwan BA, de Brouwer S; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators.

J Clin Epidemiol. 2007 Jul;60(7):720-6. Epub 2007 Feb 23.

PMID:
17573988
17.
18.

[Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates].

Loaldi A, Fabbiocchi F, Montorsi P, Guazzi M, Polese A, De Cesare N, Ravagnani P, Guazzi MD.

Cardiologia. 1989 Nov;34(11):959-66. Italian.

PMID:
2631989
19.
20.

Statin and beta-blocker therapy and the initial presentation of coronary heart disease.

Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA; Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study.

Ann Intern Med. 2006 Feb 21;144(4):229-38.

PMID:
16490908

Supplemental Content

Support Center